@cees_dekker Totally agree only engaging here to get folks to join us!

RT @cees_dekker: BLUESKY IS THE NEW TWITTER! Please join me there at (or use that handy 'tweedeck-like' app https:…

RT @cees_dekker: Okay, it is decided: I WILL LEAVE TWITTER X/twitter is passé: Elon Musk killed it, tweetdeck vanished, timeline fills u…

RT @AleksSzczurek: After being convinced by @RobKlose you can find me now at @ :)

Looking forward to sharing a new publication from the lab tomorrow! Something a bit different from us this time around. Join us over at the other place @robklose.bsky.social 🦋 if you want to find out more….

@hw1o9 See you there!

@ParasiteMatt Look forward too seeing you there!

RT @ParasiteMatt: Dear All, I have joined the flow and am on BlueSky now too. I managed to bag parasitematt there. Thanks too all other Mat…

@XRNchew See you there

RT @BungoAkiyoshi: @bungoakiyoshi.bsky.social

RT @STOPlabPI: In the other place you can find me under @stoplab.bsky.social

RT @KJArmache: Please see our paper in Nature on read-write mechanisms of H2AK119 ubiquitination by Polycomb repressive complex I. Congrats…

RT @tinekelenstra: Looking for a PhD? Want to work at a vibrant institute that fosters excellent training and science? Apply to the NKI pro…

RT @JM_Gahan: Happy to share that the Gahan lab will be branching out (or more like returning) to working on Nematostella in the near futur…

RT @NatureCellBio: 🍰Interested in reading more about the study? Here is the N&Vs article written by Fides Zenk (@EpiGN_Lab). 👉 https://t.co/…

RT @NatureCellBio: 💫NEW by @a_z_usa__ & co: JARID2-#PRC2 initiates H3K27me2 deposition in the 8-cell-to-morula transition, following H2AK11…

RT @EddaGSchulz: 📜Our GATA story is finally out in its peer-reviewed format! We even added a double deletion of GATA-responsive enhancers i…

RT @angifeldmann: Time flies - on Friday we celebrated the 3rd anniversary of our lab. I am so proud and happy to work with these wonderful…

RT @ericasieb: .@VAInstitute has 4 #postdoc positions open in labs connected with our NCI T32-funded Cancer Epigenetics Training program--P…